Tenax Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 80.7% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | -80.7% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 29,349.1% | – | – | – | 229,681.5% | – | – | – | – | – | – | – | |
| – | 28,352.7% | – | – | – | 135,057.1% | – | – | – | – | – | – | – | |
| – | 57,621.2% | – | – | – | 364,738.6% | – | – | – | – | – | – | – | |
| – | -57,701.8% | – | – | – | -364,738.6% | – | – | – | – | – | – | – | |
| – | 37.2% | – | – | – | 23.2% | – | – | – | – | – | – | – | |
| – | -55,709.8% | – | – | – | -313,350.9% | – | – | – | – | – | – | – | |
| – | 19,509.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -55,709.8% | – | – | – | -313,350.9% | – | – | – | – | – | – | – | |
| – | -55,592.0% | – | – | – | -313,351.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.